Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant - Priority Announcement: Neuromuscular Research

University of Toronto

$167,406.00

The TAR DNA-Binding Protein (TDP-43) and Amyotrophic Lateral Sclerosis

EF 2010-11

Résumé
Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, is an adult-onset neurodegenerative disease that affects motor neurons of the brain and spinal cord, causing paralysis and death within 2-5 years. There is no cure or effective treatment. A major protein associated with ALS is the TAR DNA Binding Protein (TDP-43). TDP-43 is a major component of the pathological inclusion bodies characteristic of ALS, and mutations in the TDP-43 gene are found in a subset of both familial and sporadic ALS patients. Our goal is to understand how TDP-43 could cause ALS as a means to developing strategies to treat the disease. To do this we use both studies in culture and transgenic mouse models of the disease.
Programme
Operating Grant - Priority Announcement: Neuromuscular Research
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
230648
Name
Robertson Janice
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Amyotrophic Lateral Sclerosis Society of Canada
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Systems & Circuits Neurosciences - A
Projecttitle
The TAR DNA-Binding Protein (TDP-43) and Amyotrophic Lateral Sclerosis
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$167,406
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: Neuromuscular Research
Keyworddelim
Amyotrophic Lateral Sclerosis; Neuropathology; Protein Biochemistry; Tar-Dna-Binding Protein; Transgenic Mice; Ubiquitinated Inclusions
Abstract
Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, is an adult-onset neurodegenerative disease that affects motor neurons of the brain and spinal cord, causing paralysis and death within 2-5 years. There is no cure or effective treatment. A major protein associated with ALS is the TAR DNA Binding Protein (TDP-43). TDP-43 is a major component of the pathological inclusion bodies characteristic of ALS, and mutations in the TDP-43 gene are found in a subset of both familial and sporadic ALS patients. Our goal is to understand how TDP-43 could cause ALS as a means to developing strategies to treat the disease. To do this we use both studies in culture and transgenic mouse models of the disease.
Competitiondate
201103
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Robertson, Janice
Approvedterm
3 ans 0 mois
Cihrcontribution2
Inst of Musculoskel Hlth &Arth~ $55,828~ $0~Inst of Neurosc Mental Hlth &A~ $55,828~ $0~Institute of Genetics~ $55,750~ $0~